Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors (methionine aminopeptidase type-2)

Pyrazolonaphthyridinone derivatives as MetAP2 inhibitors (methionine aminopeptidase type-2)

US Patent 9856257 · Granted Jan 2, 2018

Estimated economic value: $14,241,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic compositions against S. aureus2020
2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF recept2017
Substituted dimeric quinazoline-2,4-diones as FGF receptor agonists2015
Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof2015
2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF recept2015
FGF-receptor agonist dimeric compounds2015
FGF receptor (FGFR) agonist dimeric compounds, process for the preparation there2015
Pyridino-pyridinone derivatives, preparation and therapeutic use thereof2014
Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof2013
Use of FGF inhibiting substituted 1,2,3 indolizine derivatives in the preparatio2011
1,2,3-substituted indolizine derivatives, inhibitors of FGFs, method for prepari2010
Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for th2009